Literature DB >> 8462612

Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion.

N Tamaki1, Y Magata, N Takahashi, M Kawamoto, T Torizuka, Y Yonekura, E Tadamura, K Okuda, S Ono, R Nohara.   

Abstract

To assess the biventricular response of the clearance rate of carbon-11 acetate as an index of myocardial oxidative metabolism to increase in work-load, dynamic positron emission tomography was performed at rest and during dobutamine infusion in 14 normal subjects. The clearance rate constant (Kmono) of the left ventricular (LV) myocardium increased during dobutamine infusion (0.112 +/- 0.020 min-1 vs 0.065 +/- 0.015 min-1 at rest) (P < 0.001) in proportion to the increase in the pressure-rate product. Kmono in the right ventricular (RV) myocardium also increased (0.080 +/- 0.018 min-1 vs 0.034 +/- 0.013 min-1 at rest) (P < 0.001), with an excellent correlation with the LV Kmono (r = 0.920). The fact that the increase in RV Kmono during dobutamine infusion was greater (158% +/- 81%) than that in LV Kmono (79% +/- 39%) (P < 0.005) indicates a greater increase in oxidative metabolism in the RV in response to inotropic stimulation in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462612     DOI: 10.1007/bf00170004

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  31 in total

1.  Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.

Authors:  N Tamaki; M Kawamoto; N Takahashi; Y Yonekura; Y Magata; R Nohara; H Kambara; C Kawai; J Konishi
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

2.  Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.

Authors:  S L Meyer; G C Curry; M S Donsky; D B Twieg; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1976-07       Impact factor: 2.778

3.  Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.

Authors:  M Grover-McKay; H R Schelbert; M Schwaiger; H Sochor; P M Guzy; J Krivokapich; J S Child; M E Phelps
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

4.  C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium.

Authors:  H R Schön; H R Schelbert; G Robinson; A Najafi; S C Huang; H Hansen; J Barrio; D E Kuhl; M E Phelps
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

5.  Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.

Authors:  M Brown; D R Marshall; B E Sobel; S R Bergmann
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

Review 6.  Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing.

Authors:  H G Stratmann; H L Kennedy
Journal:  Am Heart J       Date:  1989-06       Impact factor: 4.749

7.  Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.

Authors:  M A Brown; D W Myears; S R Bergmann
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

8.  Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion.

Authors:  C Berthe; L A Pierard; M Hiernaux; G Trotteur; P Lempereur; J Carlier; H E Kulbertus
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

9.  Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease.

Authors:  J R Mason; R T Palac; M L Freeman; S Virupannavar; H S Loeb; E Kaplan; R M Gunnar
Journal:  Am Heart J       Date:  1984-03       Impact factor: 4.749

10.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

View more
  7 in total

1.  The right stuff.

Authors:  H W Strauss
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

2.  Attenuated right ventricular energetics evaluated using ¹¹C-acetate PET in patients with pulmonary hypertension.

Authors:  Keiichiro Yoshinaga; Hiroshi Ohira; Ichizo Tsujino; Noriko Oyama-Manabe; Lisa Mielniczuk; Rob S B Beanlands; Chietsugu Katoh; Katsuhiko Kasai; Osamu Manabe; Takahiro Sato; Satoshi Fujii; Yoichi M Ito; Yuuki Tomiyama; Masaharu Nishimura; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

3.  Feasibility of planar myocardial carbon 11-acetate imaging.

Authors:  L J Klein; F C Visser; S A Nurmohamed; A Vink; J H Peters; P Knaapen; P S Kruijer; J D Herscheid; G J Teule; C A Visser
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

Review 4.  Current status of viability assessment with positron tomography.

Authors:  N Tamaki
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 5.  The use of carbon 11-labeled acetate for assessment of aerobic metabolism.

Authors:  J A Melin; J L Vanoverschelde; A Bol; G Heyndrickx; W Wijns
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

6.  ATP flux through creatine kinase in the normal, stressed, and failing human heart.

Authors:  Robert G Weiss; Gary Gerstenblith; Paul A Bottomley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

7.  Assessment of coronary vasodilator reserve by N-13 ammonia PET using the microsphere method and Patlak plot analysis.

Authors:  E Tadamura; N Tamaki; Y Yonekura; T Kudoh; Y Magata; T Torizuka; M Tateno; R Nohara; S Sasayama; J Konishi
Journal:  Ann Nucl Med       Date:  1995-08       Impact factor: 2.668

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.